Do you have the same question? Follow this Question
Oct 01, 2025 - 05:56 AM
We’ve provided several answers to questions related to NovaTears (Perfluorohexyloctane) , see some other helpful Q&A related to this product.
Question: What is the protein binding of the active ingredient?
Answer: The protein binding of the active ingredient, Perfluorohexyloctane, is not applicable. This characteristic indicates that the compound remains effective on the eye surface without systemic absorption, minimizing potential side effects.
Question: What is the license status of the eye drops?
Answer: The eye drops are licensed by the EMA (European Medicines Agency). This ensures that the product meets high standards for safety and efficacy, providing consumers with confidence in its quality.
View all NovaTears (Perfluorohexyloctane) Questions & Answers
